For research use only. Not for therapeutic Use.
(R)-(-)-Ibuprofen(CAT: I003834) is the enantiomer of the widely used nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. Unlike its pharmacologically active counterpart, (S)-(+)-ibuprofen, the (R)-(-)-enantiomer exhibits minimal cyclooxygenase (COX) inhibition and anti-inflammatory effects. However, it plays a critical role in pharmacokinetic and metabolic studies, as a portion of (R)-(-)-ibuprofen is enzymatically converted to the active (S)-(+)-enantiomer in vivo. This enantiomer is valuable in chiral drug research and for investigating the stereoselective metabolism, bioavailability, and efficacy of ibuprofen. Its unique properties make it a key tool in studying the role of chirality in drug action and the development of stereospecific pharmaceuticals.
Catalog Number | I003834 |
CAS Number | 51146-57-7 |
Synonyms | (-)-Ibuprofen |
Molecular Formula | C13H18O2 |
Purity | ≥95% |
Target | NF-κB |
Solubility | 10 mM in DMSO |
Storage | -20°C |
IUPAC Name | (2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid |
InChI | InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m1/s1 |
InChIKey | HEFNNWSXXWATRW-SNVBAGLBSA-N |
SMILES | C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)O |